Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Strong Commercial Progress

19 Jun 2018 07:00

RNS Number : 7811R
Haydale Graphene Industries PLC
19 June 2018
 

 

For immediate release

19 June 2018

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Strong commercial progress in graphene-enhanced composites

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that strong commercial progress has been made with a global composite materials group (the "Customer") to enhance mechanical properties for selected products in their range of materials, through a commercially funded contract.

 

Over the last 12 months, Haydale has completed a series of pre-production trials for the Customer, who for commercial reasons cannot be named, to enhance these selected products' mechanical performance through the incorporation of graphene in a range of world-wide industrial applications. Haydale understands that the market sector for the Customers' products is significant within the global US$100bn composite market. To date, Haydale has been paid approximately US$150,000 by the Customer for these trials, which is included in the Group's current year revenue expectations. 

 

Trial quantity masterbatches were produced using Haydale's extensive knowledge of the most suitable commercially available graphene in consistent, repeatable quality. The graphene was sourced from an overseas supplier and, using Haydale's considerable in-house dispersion and mixing expertise, the required trial quantity masterbatch was produced. Crucially the trial quantities were specifically designed to be incorporated seamlessly into the Customer's production process.

 

Ray Gibbs, Chief Executive Officer of Haydale, commented: "This contract, fully funded by the Customer, is a perfect example of the work Haydale is doing across a range of composite product applications. We have experienced relatively long lead times with some of our past projects, but this one has been fast-tracked in response to the Customer's desire to launch as soon as possible." 

 

Keith Broadbent, Managing Director of Haydale's Resins, Polymers and Composites strategic business unit, said: "In a relatively short timeframe, Haydale has made excellent progress in delivering on the Customer's needs. It has been pleasing to see Haydale's composite engineers in Loughborough working well with the graphene functionalisation and dispersion team in Ammanford to combine their expertise and turn this major opportunity into a potential industrial product incorporating graphene."

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Gemma Smith Head of Marketing

Arden Partners plc (Nominated Adviser & Broker)

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Media enquiries:

Buchanan

Henry Harrison-Topham / Jamie Hooper /Gemma Mostyn-Owen

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

 

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKMGMVRRKGRZM
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.